Japan Bangladesh Friendship Hospital

ESMR

Photo: ESMR therapy.


Management of patients with advanced coronary artery disease (CAD) is a major challenge for the cardiologist and cardiac surgeon. Patients with advanced CAD frequently have limited symptoms with recurrent angina, angina at low work thresholds, breathlessness, and other debilitating conditions. These patients have often been through several “re-do” coronary bypass procedures and multiple percutaneous coronary interventions.

Surgical and interventional options for these patients typically have been exhausted or will result in only partial revascularization. Therefore, therapy remains limited to the use of multiple anti-anginal medications, reduced activity, exertion, and stress level, and significant alteration and limitation of lifestyle.

The burgeoning field of therapeutic angiogenesis offers hope for these patients. The goal of this emerging approach is to therapeutically induce the growth and development of new vasculature in zones of severe ischemia in the myocardium, with the hope that new capillaries and arterioles generated will connect to remnant existing vasculature. These neovessels are viewed to act as collaterals, perfusing ischemic territories unapproachable by macro procedures such as angioplasty and bypass surgery. A new non invasive Extracorporeal Shockwave Myocardial Revascularization (ESMR) therapy induces angiogenesis for the treatment of Angina.

ESMR innovative treatment modality can thus complement existing revascularization procedures for the treatment of Angina.

JBFH ESMR Specialist: Dr. M.A. Baqui
Doctor's Detail on the right-top column.

 

 

 

 

Our ESMR & ECP Specialist: